Join

Live Feed

Delayed 3m

Press · Analyst · Insider · SEC · FDA

Signed out · 3-min delay · Sign up for real-time

  • enCore Energy Corp. logo
    PR··Basic Materials·
    enCore Energy Receives Bureau of Land Management Authorization to Begin Construction at Dewey Burdock Uranium Project

    NASDAQ: EUTSXV: EUwww.encoreuranium.comDALLAS, June 18, 2026 /PRNewswire/ - enCore Energy Corp. (NASDAQ:EU) (TSXV:EU) (the "Company" or "enCore"), America's Clean Energy CompanyTM, today announced that the Bureau of Land Management ("BLM") has issued a final decision and approved the Dewey Burdock Uranium Project, authorizing the Company to commence infrastructure construction for the Dewey Burdock Uranium In-Situ Recovery (ISR) Project in Southwest South Dakota. With the execution of the final Environmental Assessment (EA) and Finding of No Significant Impact, the BLM authorizes enCore's wholly owned subsidiary Powertech Inc.

  • VinFast Auto Ltd. logo
    PR··Industrials·
    VinFast VF 8: The Electric SUV That Puts Family First

    IRVINE, Calif., June 18, 2026 /PRNewswire/ -- There's a particular kind of exhaustion that comes with long family road trips. The engine drone that creeps into your skull somewhere around hour three. The faint smell of gasoline that lingers after every fuel stop. The constant mental load of monitoring traffic, adjusting cruise control, and trying to hold a conversation at the same time. Most families have simply accepted this as the price of getting somewhere together. VinFast thinks differently.The VF 8, the Vietnamese automaker's flagship electric SUV now available across the United States, is built around a straightforward p

  • PowerBank Corporation logo
    PR··Utilities·
    $242.3 Million USD in Total Construction Value; PowerBank Confirms Safe Harbor of 23 Distributed Solar and Energy Storage Projects

    $94.7 Million USD Estimated Combined Value of Potential Tax Credits97 MW DC of Solar and 42 MWh of Energy Storage Across New York and PennsylvaniaProjects Expected to Power Equivalent of 11,000 HomesTORONTO, June 18, 2026 /PRNewswire/ - PowerBank Corporation (NASDAQ:PBK) (Cboe CA: PBK) (FSE: 103) ("PowerBank" or the "Company"), a leader in independent energy development and asset ownership in North America, is pleased to confirm the completion of equipment procurement agreements totaling $242.3 million USD in construction value across 23 distributed solar and energy storage projects (the "Projects") in New York and Pennsylvania through its wholly owned subsidiary Abundant Solar Power Inc. Th

  • AIRO Group Holdings Inc. logo
    PR··Industrials·
    AIRO Debuts RQ-70 Long-Range ISR Drone Platform at Eurosatory 2026, Advancing Multi-Product Growth Strategy

    AIRO Group Holdings, Inc. (NASDAQ:AIRO), a next-generation aerospace and defense company, in combination with Sky-Watch A/S, its wholly owned subsidiary, today announced the public unveiling of its RQ-70, a new deep-reach intelligence, surveillance and reconnaissance (ISR) drone, extending ISR capabilities beyond the immediate tactical frontline. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618945644/en/RQ-70 The announcement was made at Eurosatory 2026, a global event for defense and security held in Paris. AIRO expects the RQ-70 to enter full-scale production in January 2027, leveraging the Company's existing manufactur

  • Treace Medical Concepts Inc. logo
    PR··Health Care·
    Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

    PONTE VEDRA, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first case utilizing its HyperPlate™ XM Dynamic Compression Locking Implant. HyperPlate™ fixation technology further advances the SpeedPlate® implant platform by incorporating FastPitch® locking screws into the titanium compression implants to deliver rapid insertion and dynamic compression across the fusion site with enhanced multiplanar strength and stability. The HyperPlate™ XM Dynamic Com

  • BCE Inc. logo
    HIVE Digital Technologies Ltd. logo
    PR··Telecommunications·
    HIVE's BUZZ HPC Closes USD $220 Million Sovereign AI GPU Contract with Bell AI Fabric for Cohere Inc.

    This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated June 16, 2026 to its short form base shelf prospectus dated October 31, 2025.Vancouver, British Columbia--(Newsfile Corp. - June 18, 2026) - HIVE Digital Technologies Ltd. (TSX:HIVE) (NASDAQ:HIVE) (FSE: YO0) (BVC: HIVECO) (the "Company" or "HIVE"), through its wholly owned subsidiary BUZZ High Performance Computing Inc. ("BUZZ HPC"), today announced a landmark sovereign AI infrastructure deal involving Bell Canada (TSX:BCE) (NYSE:BCE) and Cohere Inc., marking a significant milestone in Canada's AI infrastructure ecosystem.The collaboration brings togeth

  • Kiora Pharmaceuticals Inc. logo
    PR··Health Care·
    Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model

    Data Presented at Epilepsy Foundation Pipeline Conference Demonstrated Significant Reduction in Epileptiform Activity: KIO-300 is the active pharmaceutical ingredient of KIO-301, Kiora's ongoing Phase 2 clinical program in vision restoration in patients with gene mutation-agnostic Retinitis PigmentosaEncinitas, California--(Newsfile Corp. - June 18, 2026) - Kiora Pharmaceuticals (NASDAQ:KPRX) today announced preclinical data showing that KIO-300, part of the company's novel ion channel modulator platform, significantly suppressed seizure-associated electrophysiological activity in an ex vivo temporal lobe epilepsy (TLE) model. The findings were presented in a poster at the Epilepsy Foundatio

  • Phio Pharmaceuticals Corp. logo
    PR··Health Care·
    Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026

    The Company invites individual and institutional investors, as well as advisors and analysts with an interest in Phio Pharmaceuticals, to attend the live, interactive presentation and one-on-one meetingsKing of Prussia, Pennsylvania--(Newsfile Corp. - June 18, 2026) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today that Robert Bitterman, CEO and Chairman of the Board, will present an overview of the Company's INTASYL® siRNA platform, including its lead clinical candidate PH-762 for the treatment of cutaneous c

  • Wayfair Inc. logo
    PR··Consumer Discretionary·
    Wayfair Expands Northeast Footprint with Princeton, New Jersey Store

    BOSTON, June 18, 2026 /PRNewswire/ -- Wayfair Inc. (NYSE:W), the destination for all things home, today announced plans to open a new large-format retail store in Princeton, New Jersey. The location, expected to open in 2027, marks an important step in expanding Wayfair's presence across the Northeast and serving customers throughout New Jersey, New York and Pennsylvania. "Opening in Princeton represents another exciting milestone as we continue expanding Wayfair's physical retail presence across America," said Liza Lefkowski, vice president of merchandising and stores at Wayfair. "We're creating a destination where customers can explore inspiring spaces, experience the quality and breadth o

  • Compugen Ltd. logo
    PR··Health Care·
    Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress

    HOLON, Israel, June 18, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered by AI/ML, today presented a trial-in-progress poster on the MAIA-ovarian adaptive platform trial of COM701, a potential first-in-class anti-PVRIG antibody, at the ESMO Gynaecological Cancers Congress 2026, in Copenhagen, Denmark. "We believe there is a strong biologic and clinical rationale for the MAIA-ovarian trial in relapsed platinum-sensitive ovarian cancer, where no standard of care for this maintenance setting exists," said Eran Ophir, Ph.D., President and CEO of Compugen. "COM701 is well tolera

  • Canadian Imperial Bank of Commerce logo
    PR··Finance·
    CIBC announces ETF series terminations and a mutual fund risk rating change

    TORONTO, June 18, 2026 /CNW/ - CIBC (TSX:CM) (NYSE:CM) – CIBC today announced it will terminate the ETF Series of the CIBC Sustainable Investment Strategies (the "Funds"), on or about November 27, 2026 (the "Termination Date"). CIBC also announced a change to the risk rating of the CIBC Dividend Income Fund effective on or about June 18, 2026. ETF Series terminationCboe ETF Series tickerFund name CSCPCIBC Sustainable Canadian Core Plus Bond Fund – ETF Series CSCECIBC Sustainable Canadian Equity Fund – ETF Series CSGECIBC Sustainable Global Equity Fund – ETF Series CSCBCIBC Sustainable Conservative Balanced Solution – ETF Series